Lower ICC risk seen in diabetes patients on metformin

12/13/2012 | Healio

Metformin-treated patients with diabetes showed a lower risk of intrahepatic cholangiocarcinoma compared with diabetes patients not taking the drug, researchers reported in Hepatology. Biliary tract disease, cirrhosis, diabetes and smoking were associated with an increased risk of ICC onset, researchers noted.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI